Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug

被引：16

作者：

Addeo, Raffaele ^{[1
]}

De Santi, M. Serena ^{[2
]}

Del Prete, Salvatore ^{[1
]}

Caraglia, Michele ^{[3
]}

机构：

[1] S Giovanni di Dio Hosp, Dept Oncol, Oncol Unit, I-80028 Naples, Italy

[2] Umberto I Hosp, Neurosurg Unit, Salerno, Italy

[3] Univ Naples 2, Dept Biochem & Biophys, I-80138 Naples, Italy

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2009年 / 64卷 / 05期

关键词：

BEVACIZUMAB PLUS IRINOTECAN; MGMT PROMOTER METHYLATION; PHASE-II TRIAL; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMAS; CHEMOTHERAPY; MULTIFORME; RADIOTHERAPY; CONCOMITANT; SURVIVAL;

D O I：

10.1007/s00280-009-1086-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：863 / 866

页数：4

共 21 条

[1]

Brandes AA, 2009, CANC CHEMOTHER PHARM

[2] Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].

Chin, L. ;

Meyerson, M. ;

Aldape, K. ;

Bigner, D. ;

Mikkelsen, T. ;

VandenBerg, S. ;

Kahn, A. ;

Penny, R. ;

Ferguson, M. L. ;

Gerhard, D. S. ;

Getz, G. ;

Brennan, C. ;

Taylor, B. S. ;

Winckler, W. ;

Park, P. ;

Ladanyi, M. ;

Hoadley, K. A. ;

Verhaak, R. G. W. ;

Hayes, D. N. ;

Spellman, Paul T. ;

Absher, D. ;

Weir, B. A. ;

Ding, L. ;

Wheeler, D. ;

Lawrence, M. S. ;

Cibulskis, K. ;

Mardis, E. ;

Zhang, Jinghui ;

Wilson, R. K. ;

Donehower, L. ;

Wheeler, D. A. ;

Purdom, E. ;

Wallis, J. ;

Laird, P. W. ;

Herman, J. G. ;

Schuebel, K. E. ;

Weisenberger, D. J. ;

Baylin, S. B. ;

Schultz, N. ;

Yao, Jun ;

Wiedemeyer, R. ;

Weinstein, J. ;

Sander, C. ;

Gibbs, R. A. ;

Gray, J. ;

Kucherlapati, R. ;

Lander, E. S. ;

Myers, R. M. ;

Perou, C. M. ;

McLendon, Roger .

NATURE, 2008, 455 (7216) :1061-1068

[3] Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation [J].

Fabi, Alessandra ;

Metro, Giulio ;

Russillo, Michelangelo ;

Vidiri, Antonello ;

Carapella, Carmine Maria ;

Maschio, Marta ;

Cognetti, Francesco ;

Jandolo, Bruno ;

Mirri, Maria Alessandra ;

Sperduti, Isabella ;

Telera, Stefano ;

Carosi, Mariantonia ;

Pace, Andrea .

BMC CANCER, 2009, 9

[4] A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma [J].

Fabrini, Maria Grazia ;

Silvano, Giovanni ;

Lolli, Ivan ;

Perrone, Franco ;

Marsella, Annarita ;

Scotti, Valerio ;

Cionini, Luca .

JOURNAL OF NEURO-ONCOLOGY, 2009, 92 (01) :79-86

[5] Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme [J].

Fazeny-Dörner, B ;

Veitl, M ;

Wenzel, C ;

Rössler, K ;

Ungersböck, K ;

Dieckmann, K ;

Piribauer, M ;

Hainfellner, J ;

Marosi, C .

BRITISH JOURNAL OF CANCER, 2003, 88 (04) :496-501

[6] INVITRO CHEMOSENSITIVITY TESTING OF FOTEMUSTINE (S-10036), A NEW ANTITUMOR NITROSOUREA [J].

FISCHEL, JL ;

FORMENTO, P ;

ETIENNE, MC ;

GIOANNI, J ;

FRENAY, M ;

DELOFFRE, P ;

BIZZARI, JP ;

MILANO, G .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) :337-341

[7] Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas [J].

Frenay, M ;

Lebrun, C ;

Lonjon, M ;

Bondiau, PY ;

Chatel, M .

EUROPEAN JOURNAL OF CANCER, 2000, 36 (08) :1026-1031

[8]

Huncharek M, 1998, ANTICANCER RES, V18, P1303

[9] Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma [J].

Kreisl, Teri N. ;

Kim, Lyndon ;

Moore, Kraig ;

Duic, Paul ;

Royce, Cheryl ;

Stroud, Irene ;

Garren, Nancy ;

Mackey, Megan ;

Butman, John A. ;

Camphausen, Kevin ;

Park, John ;

Albert, Paul S. ;

Fine, Howard A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) :740-745

[10] EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma [J].

Mukherjee, Bipasha ;

McEllin, Brian ;

Camacho, Cristel V. ;

Tomimatsu, Nozomi ;

Sirasanagandala, Shyam ;

Nannepaga, Suraj ;

Hatanpaa, Kimmo J. ;

Mickey, Bruce ;

Madden, Christopher ;

Maher, Elizabeth ;

Boothman, David A. ;

Furnari, Frank ;

Cavenee, Webster K. ;

Bachoo, Robert M. ;

Burma, Sandeep .

CANCER RESEARCH, 2009, 69 (10) :4252-4259

← 1 2 3 →